Piedmont Investment Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-8,067
| Closed | -$698K | – | 459 |
|
|
2020
Q1 | $698K | Buy |
8,067
+1,264
| +19% | +$109K | 0.03% | 367 |
|
|
2019
Q4 | $731K | Buy |
6,803
+47
| +0.7% | +$5.05K | 0.03% | 412 |
|
|
2019
Q3 | $609K | Buy |
6,756
+77
| +1% | +$6.94K | 0.02% | 449 |
|
|
2019
Q2 | $564K | Buy |
6,679
+110
| +2% | +$9.29K | 0.02% | 499 |
|
|
2019
Q1 | $579K | Buy |
6,569
+95
| +1% | +$8.37K | 0.02% | 459 |
|
|
2018
Q4 | $462K | Buy |
6,474
+25
| +0.4% | +$1.78K | 0.02% | 488 |
|
|
2018
Q3 | $793K | Buy |
+6,449
| New | +$793K | 0.03% | 358 |
|